Early Dynamics of Quantitative <i>SEPT9</i> and <i>SHOX2</i> Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
Background: The methylation status of <i>Septin 9</i> (<i>SEPT9</i>) and <i>short stature homeobox 2</i> (<i>SHOX2</i>) in circulating cell-free DNA (ccfDNA) are validated pan-cancer biomarkers. The present proof-of-concept study aimed to investigate t...
Main Authors: | Philipp Krausewitz, Niklas Kluemper, Ayk-Peter Richter, Thomas Büttner, Glen Kristiansen, Manuel Ritter, Jörg Ellinger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/18/4355 |
Similar Items
-
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
by: Thomas Büttner, et al.
Published: (2024-01-01) -
<i>SHOX</i> Deletion and Idiopathic Short Stature: What Does the Clinician Need to Know? Case Series Report
by: Maria-Christina Ungureanu, et al.
Published: (2022-12-01) -
Detection of Del/Dup Inside <i>SHOX</i>/PAR1 Region in Children and Young Adults with Idiopathic Short Stature
by: Jera Stritar, et al.
Published: (2021-09-01) -
Cell-Free Methylated <i>PTGER4</i> and <i>SHOX2</i> Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients
by: Michael Fleischhacker, et al.
Published: (2023-06-01) -
Liquid biopsy of colorectal cancer: a new approach to evaluation of aberrant methylation of the <i>SEPT9</i> gene
by: I. V. Botezatu, et al.
Published: (2021-12-01)